問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-05-31 - 2023-03-14
Condition/Disease
Test Drug
Participate Sites4Sites
Not yet recruiting2Sites
Recruiting2Sites
2021-01-07 - 2023-06-08
Not yet recruiting1Sites
Recruiting3Sites
2021-12-01 - 2029-05-10
Participate Sites3Sites
Terminated1Sites
2021-10-30 - 2022-10-18
Participate Sites2Sites
2021-11-01 - 2023-03-02
2018-10-24 - 2024-03-31
Obesity
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Participate Sites6Sites
Recruiting4Sites
Terminated2Sites
Division of Cardiovascular Diseases
2019-08-20 - 2022-03-01
Diabetes Mellitus, Type 2
Semaglutide Tablets
Terminated4Sites
2019-08-01 - 2022-03-31
type 2 diabetes mellitus
Terminated3Sites
2005-05-01 - 2006-12-31
2009-01-19 - 2010-08-31
全部
